0.313
price down icon7.67%   -0.026
after-market Handel nachbörslich: .32 0.007 +2.24%
loading

Can-Fite Biopharma Ltd ADR Aktie (CANF) Neueste Nachrichten

pulisher
04:56 AM

Can Can Fite Biopharma Ltd Sponsored ADR stock survive global slowdown2025 Price Momentum & AI Based Trade Execution Alerts - Newser

04:56 AM
pulisher
01:56 AM

Will Can Fite Biopharma Ltd Sponsored ADR stock see insider accumulation2025 Fundamental Recap & Daily Technical Forecast Reports - Newser

01:56 AM
pulisher
Dec 04, 2025

Can Can Fite Biopharma Ltd Sponsored ADR stock sustain breakout momentum2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Can Fite Biopharma Ltd Sponsored ADR stock test all time highsMarket Performance Report & Free Expert Approved Momentum Trade Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How big funds are accumulating Can Fite Biopharma Ltd Sponsored ADR stockDividend Hike & AI Enhanced Trade Execution Alerts - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Is Can Fite Biopharma Ltd Sponsored ADR stock positioned for secular growth2025 Key Lessons & Growth Focused Entry Reports - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Can Can Fite Biopharma Ltd Sponsored ADR stock deliver double digit returnsJuly 2025 Short Interest & Fast Moving Stock Watchlists - Newser

Dec 03, 2025
pulisher
Dec 01, 2025

An analyst sees good growth prospects for Can-Fite Biopharma Ltd ADR (CANF) - Setenews

Dec 01, 2025
pulisher
Nov 26, 2025

Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference - Sahm

Nov 26, 2025
pulisher
Nov 24, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Sahm

Nov 24, 2025
pulisher
Nov 24, 2025

You might want to take a look at Pasithea Therapeutics Corp (KTTA) now - Setenews

Nov 24, 2025
pulisher
Nov 20, 2025

Can-Fite’s CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil - Sahm

Nov 20, 2025
pulisher
Nov 20, 2025

Will Can Fite Biopharma Ltd Sponsored ADR stock beat revenue estimatesQuarterly Performance Summary & Scalable Portfolio Growth Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Can Fite Biopharma Ltd Sponsored ADR stock is a strong analyst pickJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can Can Fite Biopharma Ltd Sponsored ADR stock expand revenue streams - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Take off with Santech Holdings Ltd. ADR (STEC): Get ready for trading - Setenews

Nov 19, 2025
pulisher
Nov 19, 2025

How does Can-Fite Biopharma Ltd ADR (CANF) change from a tortoise to a hare? - Setenews

Nov 19, 2025
pulisher
Nov 18, 2025

Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson - Sahm

Nov 18, 2025
$39.73
price up icon 1.44%
$31.74
price down icon 0.91%
$102.52
price up icon 2.03%
$96.25
price up icon 0.27%
biotechnology ONC
$322.63
price down icon 2.61%
$204.00
price down icon 0.51%
Kapitalisierung:     |  Volumen (24h):